Lutz Lingnau
No más puestos en curso
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Mary Tagliaferri | M | 58 | 9 años | |
| R. Greer | M | 65 | 14 años | |
| Jeff Ajer | M | 61 | 7 años | |
| Myriam Curet | M | 67 | 5 años | |
| Jonathan Zalevsky | M | 49 | 9 años | |
| Vivian Wu | F | - | 6 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Howard Robin | M | 71 |
Berlex Laboratories, Inc.
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 22 años |
| John Nicholson | M | 72 | 12 años | |
| Lorianne K. Masuoka | M | 62 |
Berlex Laboratories, Inc.
Bayer Schering Pharma AG
| 10 años |
| John Stuart Patton | M | 77 | 18 años | |
| Hong Chow | M | 53 |
Bayer Schering Pharma AG
| 28 años |
| Fred Craves | M | 78 |
Berlex Laboratories, Inc.
| 3 años |
| Ho Young Huh | M | 54 | 1 años | |
| Karin Louise Dorrepaal | M | 63 |
Bayer Schering Pharma AG
| 2 años |
| Ulrich Köstlin | M | 71 |
Bayer Schering Pharma AG
| 29 años |
| Gabor M. Rubanyi | M | 77 |
Berlex Laboratories, Inc.
Bayer Schering Pharma AG
| 5 años |
| Timothy Harkness | M | 57 | - | |
| Dennis L. Winger | M | 77 | 9 años | |
| Karin Eastham | F | 74 | 5 años | |
| Susan S. Wang | F | 73 | 13 años | |
| Christopher Kuebler | M | 70 | 17 años | |
| Patti Ketchner | F | - |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 13 años |
| Maninder Hora | M | 70 | 9 años | |
| Brian Kotzin | M | 74 | 6 años | |
| Patricia P. Ketchner | F | - |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 13 años |
| Marc Rubin | M | 69 |
Bayer Schering Pharma AG
| 4 años |
| Joseph J. Krivulka | M | 73 | 13 años | |
| Bharatt Chowrira | M | 59 | 2 años | |
| Wolfgang Blossey | M | 72 | - | |
| Hans-Jürgen Schicker | M | 70 | - | |
| Rainer Hippler | M | 66 | - | |
| Werner Czaplik | M | 67 | 16 años | |
| Malte Bahner | M | 61 |
Bayer Schering Pharma AG
| - |
| Sieghardt Rometsch | M | 85 | - | |
| Rinko Ghosh | M | 60 | 13 años | |
| Michael Schirner | M | 62 |
Bayer Schering Pharma AG
| 17 años |
| Kai Licha | M | 58 |
Bayer Schering Pharma AG
| - |
| Kevin Scanlon | M | - |
Bayer Schering Pharma AG
| 4 años |
| Gisela Seidel | F | 73 | 11 años | |
| Mark de Rosch | M | 61 |
Berlex Laboratories, Inc.
| 2 años |
| Carlos A. Schuler | M | - | 6 años | |
| Robert Glanzman | M | 67 | - | |
| Deborah Charych | M | - | 8 años | |
| Raymond Jeffrey Kmetz | M | - |
Berlex Laboratories, Inc.
| 6 años |
| Ching Yau Yi | F | - | 1 años | |
| Wei Lin | M | 63 | 3 años | |
| Lisa Decker | M | 55 | 11 años | |
| Anil Singhal | M | 72 | 2 años | |
| Budi Raharjo Legowo | M | 48 |
Bayer Schering Pharma AG
| - |
| Mohamad Tabrizi | M | - | 10 años | |
| Lothar Kappich | M | 67 |
Bayer Schering Pharma AG
| 2 años |
| Heinz Georg Webers | M | 64 |
Bayer Schering Pharma AG
| 7 años |
| Javier Rodriguez | M | 52 |
Berlex Laboratories, Inc.
| - |
| John Northcott | M | 45 | 3 años | |
| Werner Breuers | M | 65 | - | |
| Theo H. Walthie | M | 76 | 12 años | |
| José Linhard Milch | M | - |
Bayer Schering Pharma AG
| - |
| Jürgen-Friedrich Kammer | M | - | - | |
| Martin Wienkenhover | M | - | 2 años | |
| Jörg Spiekerkötter | M | 66 |
Bayer Schering Pharma AG
| 7 años |
| Ulrich Freese | M | 73 | - | |
| Herman Ellman | M | 76 |
Berlex Laboratories, Inc.
| 5 años |
| Michael Brown | M | 65 | 7 años | |
| David J. Johnston | M | 61 | 3 años | |
| Douglas Fambrough | M | 55 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 3 años |
| James Niedel | M | 79 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 4 años |
| Gregory Weaver | M | 68 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | - |
| Barry Flannelly | M | 66 | 2 años | |
| John J. Schembri | M | 62 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 1 años |
| David L. Guy | M | 61 |
Bayer Schering Pharma AG
| 3 años |
| Dorian L. Rinella | F | - |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | - |
| Ivan Philip Gergel | M | 64 | 3 años | |
| James Hattersley | M | 64 | 1 años | |
| Nevan Elam | M | 56 | 3 años | |
| Randall Moreadith | M | 70 | - | |
| Roberto Guerciolini | M | 69 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 2 años |
| Dennis Langer | M | 73 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 1 años |
| Louis C. Drapeau | M | 79 | 1 años | |
| Claus Tycho Bræstrup | M | 79 |
Bayer Schering Pharma AG
| 4 años |
| Stephen Doberstein | M | 65 | 10 años | |
| Ralf Deitz | M | 62 | - | |
| Klaus Kühn | M | 72 |
Bayer Schering Pharma AG
| 17 años |
| Taneli Jouhikainen | M | 57 |
Bayer Schering Pharma AG
| 6 años |
| Nancy Hill | F | 60 |
Berlex Laboratories, Inc.
| 3 años |
| Vanessa Bhark | F | - |
Bayer Schering Pharma AG
| - |
| Michael J. Simms | M | 62 | 4 años | |
| Irwin Lerner | M | 93 | 10 años | |
| Rainer Laufs | M | 82 | 10 años | |
| Joachim von Roy | M | 79 |
Bayer Schering Pharma AG
| 1 años |
| Mark Egan | M | - |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 5 años |
| Robert A. Medv | M | 58 | 3 años | |
| Ulrich Middelmann | M | 79 | 8 años | |
| Hubertus Erlen | M | - |
Bayer Schering Pharma AG
| 35 años |
| Klaus Pohle | M | 86 |
Bayer Schering Pharma AG
| 22 años |
| Robert J. Koehler | M | 75 | 10 años | |
| Joachim-Friedrich Kapp | M | 81 |
Bayer Schering Pharma AG
| - |
| Ulrich Koemm | M | - | 3 años | |
| Rudolf Fauss | M | 72 | - | |
| Chandra Vargeese | M | 63 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 8 años |
| Stina Singel | M | 50 | 1 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 61 | 61.00% |
| Alemania | 41 | 41.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Lutz Lingnau
- Red Personal
